Navigation Links
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Date:10/2/2007

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Rajiv Malik as Executive Vice President in charge of Global Technical Operations. Mr. Malik has served in a similar capacity for Mylan since the Company acquired a controlling stake in Matrix Laboratories Limited (Matrix), where he is Chief Executive Officer, in January 2007.

As Head of Global Technical Operations, Mr. Malik will oversee the Company's global research and development (R&D) centers and manufacturing and distribution units, with responsibility for enhancing and rationalizing Mylan's global supply chain and expanded product pipeline, as well as leveraging Matrix, one of the world's largest suppliers of active pharmaceutical ingredients, across the enlarged company.

Mr. Malik has worked more than 24 years in the global generic pharmaceutical industry. In addition to his role at Mylan, Mr. Malik currently serves as Managing Director and Chief Executive Officer of Matrix. Prior to joining Matrix in 2005, he was Head of Global Development and Regulatory at Sandoz. He started his career in R&D at Ranbaxy Laboratories, rising to Head of Generics R&D.

Mylan's Vice Chairman and CEO Robert J. Coury commented, "Rajiv has been an invaluable addition to the Mylan management team since joining us in January. Since the close of the Matrix transaction, he has truly proven his capabilities and has been instrumental in the successful integration of Matrix. Rajiv has built an outstanding operational infrastructure that will allow us to capitalize on the efficiencies, synergies and sourcing opportunities we see from bringing together all three companies."

Mr. Malik earned his master's degree in pharmaceutical technology from Punjab University and has more than 60 process patents to his credit.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Where Burnt Out Executives De-stress in Natures Lap
5. Asian Business Executives Urged to Be Eco-friendly
6. BMA Welcomes Scottish Executives Move to Raise the Purchase Age of Cigarettes
7. Skin Cancer Research To Go Global
8. Dementia - a global problem
9. Obesity a global problem
10. Suggestions to reduce global heart disease burden
11. Drop in global deaths from measles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Encinitas, CA (PRWEB) , ... February 08, 2016 ... ... study showing greater than 50% lower incidence rate of type 2 diabetes in ... national averages. ”It is time to make a change in public health,” states ...
(Date:2/8/2016)... , ... February 08, 2016 , ... TopConsumerReviews.com recently awarded ... Mole removal products. , Moles are derived from a cluster of melanin when exposed ... the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is offering ... 2016 in honor of his birthday on February 10th. During this time, people ... is known by over 250,000 people from over 40 different countries as an “ordinary ...
(Date:2/8/2016)... ... 08, 2016 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase patient awareness of ... Your Mouth?” campaign to inform dentists and patients about the possible lack of ...
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... Women's Excellence ... National Wear Red Day. National Wear Red Day is the first Friday each ... Heart disease and stroke cause 1 in 3 deaths among women each year – ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016   HighPoint ... November Research Group (NRG),s pharmacovigilance technology services division.  ... consulting services and an Oracle Argus Specialized partner, ... to Life Sciences companies. --> ... expands HighPoint,s life sciences capabilities and provides a ...
(Date:2/8/2016)... PALO ALTO, Calif. , Feb. 8, 2016 ... and Kodiak Sciences Inc., a biopharmaceutical company designing and ... announced today agreements for the clinical supply of Kodiak,s ... at multiple sites, including Slough (UK), Visp (CH) and ... --> Retinal diseases, such as age-related macular degeneration ...
(Date:2/8/2016)... , Feb. 8, 2016  Avista Pharma Solutions ("Avista ... Setzer as Chief Financial Officer (CFO). Mr. Setzer is ... of experience in various roles within growing technology and ... served as the Executive Director of Finance at INC ... Raleigh, NC . Previously, Mr. Setzer served ...
Breaking Medicine Technology: